EXTENDED NATIVE CHEMICAL LIGATION
    23.
    发明公开
    EXTENDED NATIVE CHEMICAL LIGATION 审中-公开
    高级的天然化学连接

    公开(公告)号:EP1315738A1

    公开(公告)日:2003-06-04

    申请号:EP01968707.8

    申请日:2001-09-07

    IPC分类号: C07K1/00

    摘要: The invention is directed to methods and compositions for chemical ligation of components comprising a first component having a carboxythioester, and preferable an α-carboxythioester, moiety and a second component having an N-substituted, and preferably an Nα-substituted, 2 or 3 carbon chain alkyl or aryl thiol to give a ligation product having an N-substituted amide bond at the ligation site. The reactants of the invention are chemoselective, and the alkyl or aryl thiol moiety is removable from the ligation product. Removal of the alkyl or aryl thiol gives a native amide bond at the ligation site. The methods and compositions of the invention are particularly useful for ligation of peptides and polypeptides. The ligation system of the invention is applicable to a wide variety of molecules, and thus can be exploited to generate peptides, polypeptides and other amino acid containing polymers having a native amide bond at the ligation site.

    CHEMOKINE RECEPTOR MODULATORS, PRODUCTION AND USE
    25.
    发明公开
    CHEMOKINE RECEPTOR MODULATORS, PRODUCTION AND USE 审中-公开
    趋化因子受体,生产和使用的调节剂

    公开(公告)号:EP1299415A1

    公开(公告)日:2003-04-09

    申请号:EP01984163.4

    申请日:2001-07-12

    摘要: Chemokine receptor modulators comprising a chemically modified carboxyl-terminus (C-terminus) and/or amino-terminus (N-terminus) for modulating potency and pharmacokinetic properties, and methods of production and use are disclosed. The compounds and methods of the invention are exemplified by novel N-terminal, C-terminal and N/C-terminal analogs of CC and CXC chemokines. The chemokine receptor modulator analogs of the invention are useful for the treatment of disorders involving the naturally occurring chemokine that the analogs of the invention antagonize, such as for the treatment of HIV and AIDS related disorders and for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, organ transplant rejection, and rheumatoid arthritis.